Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$21.94 - $42.51 $1,842 - $3,570
-84 Reduced 75.0%
28 $1,000
Q2 2021

Aug 04, 2021

SELL
$32.94 - $56.62 $65 - $113
-2 Reduced 1.75%
112 $4,000
Q1 2021

May 05, 2021

BUY
$44.47 - $81.38 $88 - $162
2 Added 1.79%
114 $6,000
Q4 2020

Feb 04, 2021

BUY
$32.49 - $61.88 $3,638 - $6,930
112 New
112 $5,000
Q3 2019

Nov 01, 2019

SELL
$23.87 - $30.93 $453 - $587
-19 Closed
0 $0
Q2 2019

Aug 08, 2019

BUY
$22.1 - $28.56 $154 - $199
7 Added 58.33%
19 $1,000
Q1 2019

May 10, 2019

BUY
$12.0 - $25.76 $144 - $309
12 New
12 $0

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $3.14B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Glassman Wealth Services Portfolio

Follow Glassman Wealth Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.